Document
IPR2016-01127, No. 2001-5 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 1 (P.T.A.B. Sep. 9, 2016)
Cite Document
IPR2016-01127, No. 2001-5 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 1 (P.T.A.B. Sep. 9, 2016)
+ More Snippets
Document
IPR2016-01127, No. 1025-2 Exhibit - Exhibit 1025 File History of US Patent No 8,629,111 Part 2 of 4 (P.T.A.B. Jun. 3, 2016)
Cite Document
IPR2016-01127, No. 1025-2 Exhibit - Exhibit 1025 File History of US Patent No 8,629,111 Part 2 of 4 (P.T.A.B. Jun. 3, 2016)
+ More Snippets
Document
IPR2016-01127, No. 2100-221 Exhibit - National Congress of American Indians, Current Tax Needs in Indian Country (P.T.A.B. Sep. 22, 2017)
Cite Document
IPR2016-01127, No. 2100-221 Exhibit - National Congress of American Indians, Current Tax Needs in Indian Country (P.T.A.B. Sep. 22, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1033-85 Exhibit - Exhibit 1033 Mayssa Attar Professional Linkedin Profile (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01127, No. 1033-85 Exhibit - Exhibit 1033 Mayssa Attar Professional Linkedin Profile (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1036-88 Exhibit - PROTECTIVE ORDER MATERIAL Exhibit 1036 Loftsson Deposition Transcript with Errata Sheet (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01127, No. 1036-88 Exhibit - PROTECTIVE ORDER MATERIAL Exhibit 1036 Loftsson Deposition Transcript with Errata Sheet (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01127, No. 2052-63 Exhibit - Morgan Stanley Equity Research Report (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01127, No. 2052-63 Exhibit - Morgan Stanley Equity Research Report (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01127, No. 2044-58 Exhibit - FDA label for Xiidra (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01127, No. 2044-58 Exhibit - FDA label for Xiidra (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01127, No. 2001-6 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 2 (P.T.A.B. Sep. 9, 2016)
Cite Document
IPR2016-01127, No. 2001-6 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 2 (P.T.A.B. Sep. 9, 2016)
+ More Snippets
Document
IPR2016-01127, No. 1161-244 Exhibit - EX1161 SourceOne Global Partners LLC v KGK Synergize Inc (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01127, No. 1161-244 Exhibit - EX1161 SourceOne Global Partners LLC v KGK Synergize Inc (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1139-208 Exhibit - Declaration of Charles G Curtis, Jr (P.T.A.B. Sep. 21, 2017)
Cite Document
IPR2016-01127, No. 1139-208 Exhibit - Declaration of Charles G Curtis, Jr (P.T.A.B. Sep. 21, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1135-195 Exhibit - Exhibit 1135 July 6, 2017 Email (P.T.A.B. Aug. 3, 2017)
Cite Document
IPR2016-01127, No. 1135-195 Exhibit - Exhibit 1135 July 6, 2017 Email (P.T.A.B. Aug. 3, 2017)
+ More Snippets
Document
IPR2016-01127, No. 2081-190 Exhibit - GraphPad Calculation of Bloch Table 2 ¿¿¿ 3 mo C vs A (P.T.A.B. Jul. 14, 2017)
Cite Document
IPR2016-01127, No. 2081-190 Exhibit - GraphPad Calculation of Bloch Table 2 ¿¿¿ 3 mo C vs A (P.T.A.B. Jul. 14, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1088-135 Exhibit - Exhibit 1088 Refresh Products (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01127, No. 1088-135 Exhibit - Exhibit 1088 Refresh Products (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1159-242 Exhibit - EX1159 Gingras v Rosette (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01127, No. 1159-242 Exhibit - EX1159 Gingras v Rosette (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01127, No. 1154-237 Exhibit - EX1154 Excerpted Allergans Response to Motion for Summary Jugement (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01127, No. 1154-237 Exhibit - EX1154 Excerpted Allergans Response to Motion for Summary Jugement (P.T.A.B. Oct. 13, 2017)
+ More Snippets